Radiotherapy for overcoming immune checkpoint inhibitor resistance in esophageal squamous cell carcinoma
Clinical evidence for radiotherapy-immunotherapy combinations in ICI-resistant ESCC is evaluated, the distinct roles of stereotactic body radiotherapy (SBRT) and low-dose radiotherapy (LDRT), and a “barrier-exhaustion score” is proposed as a hypothetical tool to guide individualized treatment are evaluated.